| Document Date: 2007-12-05 10:33:12
Open Document File Size: 168,47 KBShare Result on Facebook
Company MedImmune Inc. / / Country United States / / Event Product Issues / Product Recall / / IndustryTerm insurance changes / treatment of established RSV disease / rubber / prevention of serious lower respiratory tract disease / / MedicalCondition bronchopulmonary dysplasia / respiratory tract disease / premature birth / arrhythmia / severe RSV disease / CHD / disease / respiratory failure / gastroenteritis / dyspnea / RSV disease / RSV infection / Carcinogenesis / severe lung infection / heart disease / anaphylaxis / thrombocytopenia / Rhinitis / infectious / Upper respiratory infection / fever / Hernia / vomiting / runny nose / urticaria / angioedema / allergic reactions / disorder / serious lung infections / hypersensitivity / diarrhea / infection / hypotonia / hepatitis / Otitis media / cough / pruritus / rash / influenza / respiratory tract infection / wheezing / serious lung infection / / MedicalTreatment open-heart surgery / bypass / / Organization FDA / / Person Prince / Nat / Van Wyke Coelingh / / / Position Prince / nurse / General / / Product Synagis / epinephrine / glycine / Rx / / ProvinceOrState Maryland / Georgia / / Technology Pharmacokinetics / antibodies / recombinant DNA technology / / URL www.synagisfacts.com / /
SocialTag |
RSV is the #1 cause of hospitalization in babies under one year of age. Steps to help protect your baby from RSV.